OCUMENSION-B: (I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: (1) REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SET OF THE SERVICE PROVIDER SUBLIMIT; (2) GRANT TO EMPLOYEE PARTICIPANTS AND CONNECTED TRANSACTION INVOLVING THE PROPOSED CONNECTED GRANT; AND (3) NOTICE OF EXTRAORDINARY GENERAL ME
Ocumension Therapeutics-B: DELAY IN DESPATCH OF CIRCULAR IN RELATION TO PROPOSED CONNECTED GRANT TO DIRECTORS UNDER THE 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: (I) GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME; (II) GRANT OF AWARDS TO EMPLOYEES UNDER THE 2021 SHARE AWARD SCHEME; AND (III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED CONNECTED GRANT TO DIRECTORS
Ocumension Therapeutics-B: GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME AND GRANT OF AWARDS UNDER THE 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: COMPLETION OF ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE
Ocumension Therapeutics-B: (1) PROPOSED ADOPTION OF THE 2021 SHARE OPTION SCHEME; (2) PROPOSED GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME; (3) CONNECTED TRANSACTION INVOLVING PROPOSED GRANT OF AWARDS UNDER THE 2021 SHARE AWARD SCHEME; (4) PROPOSE
Ocumension Therapeutics-B: DELAY IN DESPATCH OF CIRCULAR IN RELATION TO PROPOSED ADOPTION OF 2021 SHARE OPTION SCHEME, PROPOSED GRANT OF OPTIONS AND PROPOSED GRANT OF AWARDS UNDER 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: (I) PROPOSED ADOPTION OF 2021 SHARE OPTION SCHEME AND PROPOSED GRANT OF OPTIONS; (II) ADOPTION OF 2021 SHARE AWARD SCHEME; AND (III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED GRANT OF AWARDS TO DIRECTORS
Ocumension Therapeutics-B: CLARIFICATION ANNOUNCEMENT IN RELATION TO PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDERS
Ocumension Therapeutics-B: INSIDE INFORMATION PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDERS
Ocumension Therapeutics-B: (I) DISCLOSEABLE TRANSACTIONS RELATING TO THE EXCLUSIVE LICENSE AGREEMENT AND THE SHARE PURCHASE AGREEMENT AND (II) THE WARRANT SUBSCRIPTION AGREEMENT WITH ALIMERA SCIENCES, INC.
Ocumension Therapeutics-B: COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Ocumension Therapeutics-B: PLACING OF EXISTING SHARES TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Ocumension Therapeutics-B: GREEN APPLICATION FORM
Ocumension Therapeutics-B: YELLOW APPLICATION FORM
Ocumension Therapeutics-B: WHITE APPLICATION FORM
Ocumension Therapeutics-B: GLOBAL OFFERING
No Data